Home/Enthera Pharmaceuticals/Paolo Fiorina, MD

PF

Paolo Fiorina, MD

CSO, Founder

Enthera Pharmaceuticals

Therapeutic Areas

Type 1 Diabetes Inflammatory Bowel Disease Autoimmune Disorders

Enthera Pharmaceuticals Pipeline

Drug	Indication	Phase
Ent001	Type 1 Diabetes & Inflammatory Bowel Disease (Ulcerative Colitis)	Phase 1
Ebrasodebart	Autoimmune Disorders (specifics not fully detailed)	Preclinical or Early Clinical

Leadership Team at Enthera Pharmaceuticals

Lisa Maria Olson, PhD

Chief Executive Officer

Filippo Canducci, MD, PhD, MBA

Chief Medical Officer

Francesca D’addio, MD

Head of Preclinical Research, Founder

Senior Director, Finance

View full Enthera Pharmaceuticals profile